Company Filing History:
2 out of 4,548 
1 out of 2,890 
Years Active: 2002-2014
Title: Mark Zylka: Innovator in Pain Signaling Research
Introduction
Mark Zylka is a prominent inventor based in Pasadena, CA (US). He has made significant contributions to the field of pain signaling through his innovative research and inventions. With a total of 3 patents, Zylka's work focuses on understanding the molecular mechanisms involved in pain perception.
Latest Patents
Zylka's latest patents include groundbreaking inventions related to pain signaling molecules. One of his notable inventions pertains to novel genes expressed in normal but not Neurogenin-1-deficient animals. This invention specifically addresses a novel family of G protein-coupled receptors and a novel family of two-transmembrane segment proteins that are expressed in dorsal root ganglia. Additionally, he has developed a method for screening genes that are specifically expressed in nociceptive sensory neurons. Another patent involves an assay employing G protein-coupled receptors expressed in dorsal root ganglia, further emphasizing his focus on pain signaling mechanisms.
Career Highlights
Throughout his career, Mark Zylka has worked with esteemed institutions such as the California Institute of Technology and The General Hospital Corporation. His research has significantly advanced the understanding of pain mechanisms, contributing to potential therapeutic approaches for pain management.
Collaborations
Zylka has collaborated with notable colleagues, including David J. Anderson and Xinzhong Dong. These collaborations have enriched his research and expanded the impact of his inventions in the scientific community.
Conclusion
Mark Zylka's innovative work in pain signaling research has led to valuable patents that enhance our understanding of pain mechanisms. His contributions continue to influence the field and hold promise for future advancements in pain management.